Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

NCT03272971 is registered in ClinicalTrials.gov with Broncus Medical Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03272971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors
Lead sponsor
Broncus Medical Inc
Phase
Not applicable
Overall status
Terminated
Start date
December 5, 2017
Completion date
January 30, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer metastatic, lung cancer, non-small cell